Repligen Corp. (RGEN)
181.69
+0.56
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
181.69
0.00 (0.00%)
After-Hours: 20:00
Repligen Enterprise Value : 10.10B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 10.10B |
| August 20, 2026 | 10.05B |
| August 19, 2026 | 9.832B |
| August 18, 2026 | 9.256B |
| August 17, 2026 | 9.419B |
| August 14, 2026 | 9.294B |
| August 13, 2026 | 9.331B |
| August 12, 2026 | 9.230B |
| August 11, 2026 | 9.178B |
| August 10, 2026 | 9.088B |
| August 07, 2026 | 9.129B |
| August 06, 2026 | 8.877B |
| August 05, 2026 | 8.829B |
| August 04, 2026 | 8.332B |
| August 03, 2026 | 8.179B |
| July 31, 2026 | 7.837B |
| July 30, 2026 | 7.983B |
| July 29, 2026 | 7.850B |
| July 28, 2026 | 8.082B |
| July 27, 2026 | 7.276B |
| July 24, 2026 | 7.327B |
| July 23, 2026 | 7.645B |
| July 22, 2026 | 7.785B |
| July 21, 2026 | 7.610B |
| July 20, 2026 | 8.090B |
| Date | Value |
|---|---|
| July 17, 2026 | 8.189B |
| July 16, 2026 | 8.263B |
| July 15, 2026 | 8.235B |
| July 14, 2026 | 8.183B |
| July 13, 2026 | 8.056B |
| July 10, 2026 | 8.020B |
| July 09, 2026 | 8.003B |
| July 08, 2026 | 7.634B |
| July 07, 2026 | 7.771B |
| July 06, 2026 | 7.863B |
| July 02, 2026 | 7.916B |
| July 01, 2026 | 7.723B |
| June 30, 2026 | 7.579B |
| June 29, 2026 | 7.630B |
| June 26, 2026 | 8.194B |
| June 25, 2026 | 8.094B |
| June 24, 2026 | 7.709B |
| June 23, 2026 | 7.030B |
| June 22, 2026 | 7.042B |
| June 18, 2026 | 7.349B |
| June 17, 2026 | 7.435B |
| June 16, 2026 | 7.330B |
| June 15, 2026 | 7.284B |
| June 12, 2026 | 7.268B |
| June 11, 2026 | 7.423B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioLife Solutions, Inc. | 1.747B |
| Danaher Corp. | 177.35B |
| Liquidia Corp. | 6.013B |
| Harmony Biosciences Holdings, Inc. | 1.770B |
| Agilent Technologies, Inc. | 46.42B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.008M |
| Revenue (Quarterly) | 204.13M |
| Total Expenses (Quarterly) | 199.12M |
| EPS Diluted (Quarterly) | 0.0884 |
| Gross Profit Margin (Quarterly) | 49.25% |
| Profit Margin (Quarterly) | 2.45% |
| Earnings Yield | 0.40% |
| Operating Earnings Yield | 0.69% |
| Normalized Earnings Yield | 0.4492 |